Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18049729rdf:typepubmed:Citationlld:pubmed
pubmed-article:18049729lifeskim:mentionsumls-concept:C0040077lld:lifeskim
pubmed-article:18049729lifeskim:mentionsumls-concept:C0162675lld:lifeskim
pubmed-article:18049729lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:18049729pubmed:issue47lld:pubmed
pubmed-article:18049729pubmed:dateCreated2007-11-30lld:pubmed
pubmed-article:18049729pubmed:abstractTextNeutron capture therapy (NCT) is a binary radio-chemotherapeutic modality for the treatment of cancer. A major focus of NCT-related research is the development of novel tumor-selective agents that serve as the chemical component in NCT. Thymidine analogues substituted with a boron-containing carborane cluster at the N3 position, designated 3CTAs (3-carboranyl thymidine analogues), constitute one class of these new improved NCT agents. Their chemical, structural and biological properties are discussed in this Feature Article.lld:pubmed
pubmed-article:18049729pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18049729pubmed:languageenglld:pubmed
pubmed-article:18049729pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18049729pubmed:citationSubsetIMlld:pubmed
pubmed-article:18049729pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18049729pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18049729pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18049729pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18049729pubmed:statusMEDLINElld:pubmed
pubmed-article:18049729pubmed:monthDeclld:pubmed
pubmed-article:18049729pubmed:issn1359-7345lld:pubmed
pubmed-article:18049729pubmed:authorpubmed-author:BarthRolf FRFlld:pubmed
pubmed-article:18049729pubmed:authorpubmed-author:TjarksWernerWlld:pubmed
pubmed-article:18049729pubmed:authorpubmed-author:ByunYoungjooYlld:pubmed
pubmed-article:18049729pubmed:authorpubmed-author:TiwariRohitRlld:pubmed
pubmed-article:18049729pubmed:authorpubmed-author:NarayanasamyS...lld:pubmed
pubmed-article:18049729pubmed:issnTypePrintlld:pubmed
pubmed-article:18049729pubmed:day21lld:pubmed
pubmed-article:18049729pubmed:ownerNLMlld:pubmed
pubmed-article:18049729pubmed:authorsCompleteYlld:pubmed
pubmed-article:18049729pubmed:pagination4978-91lld:pubmed
pubmed-article:18049729pubmed:meshHeadingpubmed-meshheading:18049729...lld:pubmed
pubmed-article:18049729pubmed:meshHeadingpubmed-meshheading:18049729...lld:pubmed
pubmed-article:18049729pubmed:meshHeadingpubmed-meshheading:18049729...lld:pubmed
pubmed-article:18049729pubmed:meshHeadingpubmed-meshheading:18049729...lld:pubmed
pubmed-article:18049729pubmed:meshHeadingpubmed-meshheading:18049729...lld:pubmed
pubmed-article:18049729pubmed:meshHeadingpubmed-meshheading:18049729...lld:pubmed
pubmed-article:18049729pubmed:meshHeadingpubmed-meshheading:18049729...lld:pubmed
pubmed-article:18049729pubmed:meshHeadingpubmed-meshheading:18049729...lld:pubmed
pubmed-article:18049729pubmed:year2007lld:pubmed
pubmed-article:18049729pubmed:articleTitleCarboranyl thymidine analogues for neutron capture therapy.lld:pubmed
pubmed-article:18049729pubmed:affiliationCollege of Pharmacy, The Ohio State University, Columbus, OH 43210, USA. tjarks.1@osu.edulld:pubmed
pubmed-article:18049729pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18049729pubmed:publicationTypeReviewlld:pubmed
pubmed-article:18049729pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18049729pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed